专利号:US-2006234990-A1 优先权日:1999-04-30 标题 :Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions 发明人:MAJEED MUHAMMED; BADMAEV VLADIMIR 权利人:SAMI LABS LTD 摘要:A method of treatment of lymphoproliferative and autoimmune disorders with a new composition of four boswellic acids including β-boswellic acid, 3-O-acetyl-β-boswellic acid, 11-keto-β-boswellic acid, and 3-O-acetyl-11-keto-β-boswellic acid. Boswellic acids of invention have been obtained in a novel industrial process from the gum resin of Boswellia serrata tree, providing standardized composition which inhibits DNA, RNA and protein synthesis of the target cell without cytotoxic effects. The composition of invention provides advantage of irreversible cytostatic therapy, equivalent to biological effects of a cytotoxic therapy without killing body cells.
专利号:WO-2008058514-A1 优先权日:2006-11-14 标 题:Preparations comprising boswellic acids for inhibiting the synthesis of prostaglandin e2 发明人:WERZ OLIVER; SIEMONEIT ULF 权利人:UNIV EBERHARD KARLS; WERZ OLIVER; SIEMONEIT ULF 摘要:The present invention relates to the use of preparations with pentacyclic triterpenoic acids and structural derivatives thereof, in particular boswellic acids from Boswellia species (such as B. serrata, B. carterii, B. sacra), for inhibiting the inducible mitochondrial prostaglandin E2 synthase-1. In addition, the invention relates to the use of pentacyclic triterpenoic acids and derivatives thereof for producing a medicament for the treatment of PGE2-mediated diseases.
专利号:WO-02085921-A3 优先权日:2001-03-01 标题 :Simple method for the synthesis of boswellic acids and derivatives thereof 发明人:JAUCH JOHANN 权利人:JAUCH JOHANN 摘要:The invention relates to a method for producing a pure boswellic acid from a boswellic acid mixture, comprising the following steps; (a) acetylation by a suitable acetylation reagent or deacetylation by a suitable deacetylation reagent, (b) oxidation by a suitable oxidation reagent or reduction by a suitable reduction reagent. The invention also relates to boswellic acids which are produced according to said method as well as pharmaceutical formulations thereof.
专利号:WO-02085921-A2 优先权日:2001-03-01 标 题 :Simple method for the synthesis of boswellic acids and derivatives thereof
专利号:CN-116355034-A 优先权日:2021-12-28 标 题 :Synthesis of AKBA Compounds and Their Application in Antineoplastic Drugs
专利号:US-2015183823-A1 优先权日:2009-04-17 标题:Cosmetic or pharmaceutical compositions including tripeptides capable of stimulating cyclic adenosine monophosphate synthesis and their use in the treatment and/or care of the skin and/or hair
参考文献:10.1055/s-2006-931536 摘要:Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab M. Modulation of Pgp function by boswellic acids. Planta Med. 2006 May;72(6):507–13. doi: 10.1055/s-2006-931536. 参考文献:10.1007/s00436-012-3237-7 摘要:Liu M, Chen P, Büchele B, Dong S, Huang D, Ren C, Zhang Y, Hou X, Simmet T, Shen J. A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicum. Parasitol Res. 2013 Mar;112(3):1105–11. doi: 10.1007/s00436-012-3237-7. 参考文献:10.1155/2019/3041438 摘要:Morsy MA, Patel SS, El-Sheikh AAK, Savjani JK, Nair AB, Shah JN, Venugopala KN. Computational and Biological Comparisons of Plant Steroids as Modulators of Inflammation through Interacting with Glucocorticoid Receptor. Mediators of Inflammation. 2019 May 27;2019():1–9. doi: 10.1155/2019/3041438. 参考文献:10.1002/biot.202100044 摘要:Vakilian S, Alam K, Al-Kindi J, Jamshidi-Adegani F, Rehman NU, Tavakoli R, Al-Riyami K, Hasan A, Zadjali F, Csuk R, Al-Harrasi A, Al-Hashmi S. An engineered microfluidic blood-brain barrier model to evaluate the anti-metastatic activity of β-boswellic acid. Biotechnol J. 2021 Oct;16(10):e2100044. doi: 10.1002/biot.202100044. 参考文献:10.4251/wjgo.v14.i2.450 摘要:Zheng P, Huang Z, Tong DC, Zhou Q, Tian S, Chen BW, Ning DM, Guo YM, Zhu WH, Long Y, Xiao W, Deng Z, Lei YC, Tian XF. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450–77.